Back

The Cardiovascular Disease Burden Associated with secondhand smoke, 1990-2019: an age-period-cohort analysis of the Global Burden of Disease study

31 August 2024 (14:00 - 14:40)
Organised by: Logo
Congress Presentation Part of: Smoking, mental health, and heart disease Epidemiology ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Hong Jiang

Fuwai Hospital Chinese Academy of Medical Sciences, Beijing (China)

6 More presentations in this session

Presentation thumbnail
The identification, referral and management of patients with cardiac-related distress: a new model to support psychological recovery after a cardiac event
Professor A. Jackson (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
Immunoglobulin free light chain-kappa, a novel biomarker of inflammation and cardiovascular risk, decreases after smoking cessation in association with NT-proBNP
Professor K. Hasegawa (Kyoto, JP)
Abstract Slides Video
Presentation thumbnail
Smoking cessation medicines and e-cigarettes in smokers with obesity
Doctor D. Terentes-Printzios (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Fear of recurrence and its association with mental health outcomes after spontaneous coronary artery dissection (SCAD)
Ms S. Clarke (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
Score-2 in heavy smokers: are we underestimating the risk?
Doctor D. Cosmi (Perugia, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Smoking, mental health, and heart disease

The Event

Event poster

ESC Congress 2024

31 August 2024 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Global, regional and national burden of ischemic heart disease and its attributable risk factors from 1990 to 2021: a systematic analysis of the Global Burden of Disease Study 2021
thumbnail
Congress Presentation
The Global Burden of Disease Study: transforming cardiovascular epidemiology and policy
thumbnail
Congress Session
Global burden of cardiovascular disease and risks: what should European cardiovascular clinicians do?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources